Antimicrobial therapy for anthrax.
Torres-Tortosa
M
M
Caballero-Granado
F J
FJ
Moreno
I
I
Canueto
J
J
D000881:Anthrax / Q000175:diagnosis* / Q000188:drug therapy*; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000008:administration & dosage; D001408:Bacillus anthracis / Q000187:drug effects* / Q000302:isolation & purification; D023482:Bioterrorism; D002939:Ciprofloxacin / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002939:Ciprofloxacin